NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
53 hedge funds and large institutions have $53.6M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
71% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 21
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $110K
Holders
53
Holding in Top 10
3
Calls
–
Puts
$110K
Top Buyers
| 1 | +$1.15M | |
| 2 | +$1.09M | |
| 3 | +$762K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$271K |
| 5 |
ECM
Element Capital Management
New York
|
+$226K |
Top Sellers
| 1 | -$2.35M | |
| 2 | -$768K | |
| 3 | -$465K | |
| 4 |
O
OrbiMed
New York
|
-$350K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$247K |